Exchange: NASDAQ·Updated 07:59 PM EST

CLRB Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 10

Estimated EPS

-$0.56

Reported EPS

-$0.46

Surprise

+17.34%

Estimated Rev

$0M

Reported Rev

---

Surprise

---

• Reported GAAP EPS of -$0.46 up 67.38% YoY • Cellectar believes its September 30, 2026 cash balance is adequate to fund budgeted operations into the second quarter of 2027; Phase 3 dosing remains on track for Q1 2027, with NDA submission planned in 1H27.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.49
--
--
N/A
Q3 '26
-$0.56
-$0.46
17.34%
BEAT
Q2 '26
-$0.59
-$0.57
2.98%
BEAT
Q1 '26
-$1.88
-$1.33
29.44%
BEAT
Q4 '25
-$1.22
$0.65
153.07%
BEAT

Advertisement|Remove ads.